Viperin is a radical S-adenosylmethionine (SAM) enzyme that plays a multifaceted role in the cellular antiviral response; however, the mechanism by which viperin mediates its antiviral effects remains unknown. Viperin is implicated regulating K63-linked poly-ubiquitination of interleukin-1 receptor-associated kinase-1 (IRAK1) by the E3 ubiquitin ligase TNF ReceptorAssociated Factor 6 (TRAF6) as part of the Toll-like receptor-7 and 9 (TLR7/9) innate immune signaling pathways. We show that poly-ubiquitination of IRAK1 requires the association of viperin with IRAK1 and TRAF6 and is SAM-dependent. Furthermore, IRAK1 and TRAF6 activate viperin to reductively cleave SAM in the presence of either ATP or CTP. Based on these and other observations, we propose a mechanism in which SAM cleavage switches the viperin-IRAK1-TRAF6 complex between poly-ubiquitination-active and inactive states, thereby regulating TLR7/9 signaling. This finding represents a new regulatory mechanism for protein post-translational modifications by radical SAM enzymes that may also explain viperin's seemingly unconnected antiviral effects.
Introduction
The innate immune system is involved in the initial detection of pathogens and coordinates the host's first line of defense against infection. 1 Viperin (Virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible (also denoted as RSAD2 or Cig5 in humans) is an interferon-inducible protein that is up-regulated in response to viral infection ( Fig.   1a ) 2, 3, 4 . An N-terminal membrane-associated domain localizes viperin to the endoplasmic reticulum and lipid droplets, which are the assembly and replication sites for various viruses 5, 6, 7, 8 . Numerous studies have demonstrated viperin's role in restricting the infectivity of a range of viruses including HIV-1, influenza A, human cytomegalovirus (HCV), Bunyamwera virus and tick-borne encephalitis virus (TBEV), 3, 4, 9, 10, 11, 12 but no unified biochemical mechanism of action has immerged so far. Viperin has been reported to interact with a variety of host and viral proteins, among which are farnesyl pyrophosphate synthase 13 , the mitochondrial trifunctional protein 14 , the viral nonstructural protein 5A (NS5A) 11 and the pro-viral host factor, vesicleassociated protein-A 15 . Most likely, viperin causes its targets to be degraded by the cell, thereby inhibiting metabolic pathways important for viral replication.
Viperin is unusual in being one of only eight radical SAM enzymes found in animals 16 . The vast majority of radical SAM enzymes catalyze reactions unique to microbial metabolism, which are initiated by the reductive cleavage of SAM to generate a 5′-deoxyadenosyl radical 16, 17, 18, 19, 20, 21 . The recently determined crystal structure of mouse viperin 5 shows that it adopts the canonical (βα) 6 -partial barrel fold observed for radical SAM enzymes 20 , in which the catalytically essential [4Fe-4S] cluster is ligated by the three cysteinyl residues of the hallmark CxxxCxxC motif (Fig.   1b ) 5 . The structural similarity of viperin to MoaA, a radical SAM enzyme that catalyzes the first step in molybdoterin biosynthesis using GTP as a substrate 22 , has led to studies that suggest that viperin catalyzes reactions on small molecule(s) rather than on proteins 23 .
However, it is unclear how viperin's anti-viral properties depend upon its radical SAM activity, or what viperin's real substrate(s) are 12 . Furthermore, it appears that the radical SAM activity of viperin may be dispensable in some cases, such as restricting influenza A infection, 24 . Viperin, or viperin-like sequences have been identified in all kingdoms of life, which suggests a conserved biochemical function for the enzyme that may extend beyond the antiviral properties associated with its expression in animals 3, 4, 25, 26 .
Recently, a connection between viperin and innate antiviral signaling has emerged. Tolllike receptor 7 (TLR7) and TLR9 are among various pattern recognition receptors that sense viral nucleic acids and induce production of type I interferons by plasmacytoid dendritic cells (pDCs) to protect the host from viral infection. Viperin has been implicated as a component of the signaling pathway that leads to type I interferon production 27, 28 . Viperin stimulates the K63-linked poly-ubiquitination of the IL-1R-associated kinase (IRAK1) by the E3 ubiquitin ligase, TNFR-associated factor 6 (TRAF6) 28, 29 . K63-linked poly-ubiquitination, in turn, activates IRAK1 to phosphorylate interferon regulatory factor 7 (IRF7), causing IRF7 to migrate to the nucleus where it activates transcription of type-1 interferons (Fig. 1a ) 30, 31 .
To examine the biochemical mechanism underling viperin's seemingly unconnected modes of action, we have reconstituted the interactions between viperin, IRAK1 and TRAF6 that lead to poly-ubiquitination of IRAK1 in HEK 293T cells. Based on our experiments, we propose that viperin regulates IRAK1 poly-ubiquitination in a manner that is controlled by the reductive cleavage of SAM and linked to cellular nucleotide pool. This mechanism reconciles many seemingly contradictory findings and may explain the mechanism of action of viperin on other cellular and viral protein targets.
Results
Viperin was initially implicated as a component the TLR7 and TLR9 signaling pathways leading to type-1interferon production in experiments using pDCs derived from transgenic mice 27, 28 . These studies focused on defining the signaling pathway, however they did not address the enzymatic function of viperin. To examine this question, we sought to reconstitute the interactions between viperin, TRAF6 and IRAK1 by transient expression of these proteins in HEK 293T cells. This allowed us to examine a specific biochemical function of viperin -activation of IRAK1 by poly-ubiquitination -in a system that maintains the necessary cellular context for the enzyme to be functional. In particular, expression in eukaryotic cells allows viperin to localize to the ER membrane and lipid droplets and provides the additional components necessary for protein ubiquitination.
Viperin forms a complex with IRAK1 and TRAF6 at the ER membrane
We first sought to establish that viperin directly interacts with IRAK1 and TRAF6 to stimulate poly-ubiquitination of IRAK1, rather than through other intermediary protein(s). The interaction between viperin, IRAK1 and TRAF6 was examined by co-immunoprecipitation using The N-terminal domain of viperin serves to localize the enzyme to the cytoplasmic face of lipid droplets and the endoplasmic reticulum (ER) 8 , whereas TRAF6 and IRAK1 are cytosolic enzymes 32 . Therefore, we examined whether co-expression of viperin with TRAF6
and IRAK1 caused these enzymes to re-localize to the ER membrane. Confocal immunofluorescence microscopy of HEK 293T cells co-transfected with IRAK1 and TRAF6
confirmed that in the absence of viperin these proteins are, as expected, distributed diffusely in staining for viperin (green) and TRAF6 (red) demonstrates co-localization (yellow). Coexpression of IRAK with viperin appears to result in IRAK1 also forming punctate structures that do not co-localize (middle panels). The reason for this is currently unclear.
the cytoplasm (Fig. 2b) . In contrast, co-expression with viperin resulted in TRAF6 and IRAK1 localization to the ER membrane. Co-expression of IRAK1 alone with viperin resulted in IRAK1 partially localizing to the ER membrane. However, no localization of TRAF6 to the ER membrane was observed when viperin and TRAF6 were co-expressed ( Supplementary Fig. 5 ).
These observations are consistent with the immunoprecipitation results. Interestingly, when cells expressing viperin-Δ3C were examined, this mutant did not appear to localize to the ER membrane but remained cytosolic despite the presence of the N-terminal ER-localization domain ( Supplementary Fig. 3 ). This precluded using viperin-Δ3C to conduct co-localization studies with IRAK1 and TRAF6.
Viperin is required for poly-ubiquitination of IRAK1
Viperin was initially implicated in the K63-linked poly-ubiquitination of IRAK1 by the E3 ubiquitin ligase TRAF6 based on studies that used mouse-derived viperin +/+ and viperin -/-pDC cells. The TLR7/9 signaling pathways were stimulated in these cells with either dsRNA or lipopolysaccharides to induce viperin expression. 27, 28 We sought more direct evidence of viperin's involvement in the poly-ubiquitination of IRAK1 by recapitulating the system in HEK 293T cells. Cells were co-transfected with viperin and IRAK1 or TRAF6, or both, and harvested after 36 h. Cell extracts were analyzed by immunoblotting and probed with antibodies against IRAK1 or ubiquitin.
Viperin significantly stimulated poly-ubiquitination of IRAK1, as evidenced by the appearance of high molecular weight bands in immunoblots probed with polyclonal antiubiquitin antibodies (Fig. 3a) . This finding indicates that viperin (when co-expressed with IRAK1) is able to either recruit endogenous TRAF6 and/or other E3 ubiquitin ligases to polyubiquitinate IRAK1 28, 33 . In contrast, the inactive viperinΔ3C mutant failed to stimulate poly- poly-ubiquitination of IRAK1 (Fig. 3a) . Co-expression of TRAF6 with IRAK1 and viperin did not significantly alter the overall level of ubiquitination (Fig. 3b) , but rather resulted in a shift to higher molecular weight isoforms of poly-ubiquitinated IRAK1. We note that it is these longchain ubiquitinated forms that are implicated in the activation of IRAK1 towards phosphorylation of IRF7, which is the penultimate step in TLR7/9 signaling 30, 31 . Interestingly, very little poly-ubiquitination of IRAK1 by TRAF6 was evident in the absence of viperin, even though these proteins were expressed at very high (non-physiological) cellular concentrations.
This finding underscores the necessity of the interaction between viperin, IRAK1 and TRAF6 for poly-ubiquitination of IRAK1 to occur.
SAM is required for viperin to stimulate poly-ubiquitination of IRAK1
To investigate whether SAM was required for viperin to stimulate poly-ubiquitination of IRAK1, we examined the effect of depleting cellular SAM levels using cycloleucine, which is an inhibitor of SAM synthase 34 . Cycloleucine (50 mM) was added to the cell culture medium 12 h post-transfection and then the levels of cellular viperin were monitored for a period of 7 h.
Surprising, we found that treatment with cycloleucine significantly reduced the half-life of viperin in the cells (Fig. 4a ). This observation suggests that SAM binding to viperin stabilizes its structure, with viperin being subject to degradation in the absence of SAM. In the presence of cycloleucine, no poly-ubiquitination of IRAK1 was observed in cells expressing viperin, IRAK1
and TRAF6 (Fig. 4b) . The lack of poly-ubiquitination could be a consequence either of the low levels of viperin expression under these conditions, or the low levels of SAM. To clarify this observation, examined the stability of the viperinΔ3C mutant, which is unable to cleave SAM.
When we expressed viperinΔ3C in HEK293T cells, we found that the mutant enzyme had a much shorter half-life than wild-type viperin, even in the absence of cycloleucine, (Fig. 4a ).
This result suggested that removing the iron-sulfur cluster significantly destabilizes the protein's structure, so that SAM may not bind to the mutant enzyme. We therefore examined the effect of sinefungin, a tight-binding competitive inhibitor of many SAM-dependent enzymes 35 , on the stability of viperinΔ3C. Sinefungin (20 nM) was added to the cell culture medium 4 h posttransfection and then the cellular levels of viperinΔ3C were followed for a further 12 h.
Sinefungin effectively stabilized viperinΔ3C, thereby extending its cellular half-life to that of wild-type viperin (Fig. 4a) . This observation suggested that sinefungin might stabilize the enzyme's structure.
Therefore, we examined whether, by stabilizing its structure, sinefungin could rescue the ability of the viperinΔ3C mutant to stimulate poly-ubiquitination of IRAK1 by TRAF6.
HEK293T cells were co-transfected with viperinΔ3C, IRAK1 and TRAF6 and 8 h posttransfection treated with sinefungin (20 nM, final concentration). The cells were cultured for a further 12 h , harvested and analyzed by immunoblotting for the presence of poly-ubiquitinated forms of IRAK1. We found that sinefungin does indeed rescue the ability of viperinΔ3C to stimulate poly-ubiquitination of IRAK1 (Fig. 4b) . Lower levels of poly-ubiquitinated IRAK1
were seen in sinefungin-treated cells expressing only viperinΔ3C and IRAK1, suggesting that sinefungin-bound viperinΔ3C may recruit endogenous E3 ubiquitin ligases (Fig 4b) . These observations imply that SAM (or a SAM analog) must be bound to viperin for it to form an active complex with IRAK1 and TRAF6.
Based on this observation, we hypothesized that 5'-dA, as the product of SAM cleavage, might inhibit viperin's ability to stimulate poly-ubiquitination of IRAK1. HEK 293T cells were co-transfected with wild-type viperin, TRAF6 and IRAK1 and treated with 5'-dA (5 µM final concentration). The treated cells were harvested after 12 h and analyzed by immunoblotting for the presence of poly-ubiquitinated IRAK1. In this case, we observed that 5'-dA significantly reduced the level of poly-ubiquitinated IRAK1 (Fig. 4b) , suggesting that 5'-dA inhibits wild-type viperin's ability to stimulate poly-ubiquitination of IRAK1.
IRAK1 and TRAF6 activate viperin towards reductive cleavage of SAM
The contrasting effects of 5'-dA and sinefungin on the abilities of wild-type viperin and viperinΔ3C to stimulate the poly-ubiquitination of IRAK1, suggested that the radical SAM activity of viperin might serve as a regulatory mechanism to control the poly-ubiquitination of IRAK1. Therefore, we examined whether co-expression of IRAK1 and TRAF6 had any effect on the reductive cleavage of SAM catalyzed by viperin. Extracts of HEK 293T cells transfected with viperin, IRAK1 and TRAF6 were prepared and assayed under anaerobic conditions for viperin activity, which was quantified by measuring the formation of 5'-dA formed through the reductive cleavage of SAM ( Supplementary Fig. 6 ). To normalize the data, the amount of viperin present in the cell extracts was quantified by immunoblotting, as described in the Methods section ( Supplementary Fig. 7 ).
In cell extracts expressing only viperin, only 0.94 ± 0.05 molecules of 5'-dA per molecule of viperin were generated in 1 h ( Fig. 5 ; Table 1 ). However, when viperin was co-expressed with both IRAK1 and TRAF6, a 4-fold increase in the amount of 5'-dA produced was observed (k obs = 4.30 ± 0.21 h -1 ). Co-expression of viperin with IRAK1 alone resulted in a smaller, 2-fold, increase in 5'-dA formation, whereas co-expression of viperin with TRAF6 alone had no effect on 5'-dA formation, which is consistent with the lack of interaction between these two enzymes. Negligible amounts of 5'-dA were formed in cell extracts either lacking viperin or in cells expressing viperinΔ3C. in the assay resulted in a 2.4 -2.7-fold increase in the amount of 5'-dA formed in cell extracts expressing viperin ( Fig. 5 ; Table 1 ), indicating that ATP and CTP may also be substrates for viperin. In contrast, inclusion of 300 µM UTP or GTP provided no increase in 5'-dA, demonstrating that viperin has specificity for certain nucleotides. As typical cellular nucleotide triphosphate concentrations range from 1 -10 mM for ATP and ~ 400 µM for CTP 39 , this observation suggests that these nucleotides are likely to be physiological substrates for viperin.
IRAK1 and TRAF6 and either ATP or CTP synergistically activate viperin
Significantly, a large increase in viperin's radical SAM activity was observed when either ATP or CTP were added to lysates prepared from cells co-expressing viperin, IRAK1 and Our experiments allow us to posit the following mechanism for viperin, depicted in Fig. 6 , in which the reductive cleavage of SAM serves as a switch to regulate the TLR7/9 signaling pathway in a manner analogous to signal regulation by hetero-trimeric G proteins 40, 41 . In the absence of SAM, viperin is in an inactive conformation (apo-form) that is unable to stimulate ubiquitination of IRAK1. Upon binding SAM, viperin undergoes a conformational change to an active state (holo-form) that stimulates K63-linked poly-ubiquitination of IRAK1 by TRAF6 (or other E3 ligases). This step of the mechanism is supported by the fact that viperinΔ3C, which cannot catalyze reductive cleavage of SAM, is rescued by the SAM analogue, sinefungin. Once When complexed with IRAK1 and TRAF6, viperin is activated to cleave SAM. The large increase in radical SAM activity elicited by ATP or CTP indicates that these nucleotides are cosubstrates for viperin. We postulate that cleavage of SAM, leading to the formation of 5'-dA returns the viperin to its inactive state, preventing further poly-ubiquitination of IRAK1. This aspect of the mechanism is supported by inhibitory effect of 5'-dA on poly-ubiquitination of IRAK1. The slow rate, for an enzymatic reaction, at which viperin cleaves SAM makes this reaction well suited to serve as a "radical clock" to regulate a signaling pathway. Based on the rate of 5'-dA formation, we estimate that viperin remains in the active state for an average of 2.5 min before cleavage of SAM reverts it to its inactive state.
The activation of viperin by ATP and CTP intriguingly hints at a mechanism by which viperin and by extension TLR7/9 signaling could be modulated by the cellular nucleotide pool.
It is currently unclear how viperin modifies these nucleotides, assuming, as seems very likely, that they are true substrates for viperin, as opposed to simply activators of the enzyme.
Unfortunately, the extremely small amounts of material produced in these experiments precluded us from characterizing the modified nucleotides. An interesting possibility is that the modified nucleotides might serve as novel second messengers that could regulate other cellular pathways involved in the innate immune response. It is also intriguing that, in vitro, viperin is reported to be activated to cleave SAM by geranyl-and farnesyl-pyrophosphate 38 , which are key intermediates in isoprenoid biosynthesis. Other than their phosphate groups, these molecules have no structural similarity to CTP or ATP. This observation suggests that viperin might bind, and by extension be regulated by, a range of phosphorylated cellular metabolites.
In conclusion, our experiments establish a unifying mechanistic hypothesis for viperin that rationalizes many of the seemingly unconnected observations regarding the function of this intriguing enzyme. We note that protein ubiquitination plays multiple roles in cellular proteostasis and signal transduction 42, 43 . We suggest that the wide-ranging roles that viperin plays in the antiviral response could result from the ability of the enzyme to recruit and activate a subset of the many E3 ubiquitin ligases present in the cell to ubiquitinate target proteins, thereby regulating their cellular levels in response to viral infection. Lastly, we note that the utilization of radical SAM chemistry as a "radical clock" to regulate the activity of other cellular proteins constitutes new role for this ancient and diverse class of enzymes.
Methods

Materials
Cell lines
The HEK293T cell line was obtained from ATCC.
Antibodies
Rabbit polyclonal RSAD2/ Viperin antibody (11833-1-AP) was obtained from Protein Tech. 
Immunoblotting
Cells were lysed in TBST buffer (20 mM Tris (pH 7.5), 500 mM NaCl, 0.05% Tween-20)
containing protease inhibitors (SIGMAFAST TM Protease Inhibitor Tablets, S8830; Sigma).
Supernatants of lysates were collected and mixed with reducing sample buffer. The supernatants were separated on 10% SDS-PAGE gels. The bicinchoninic acid (BCA) assay (Thermo Scientific) was used to determine the total amount of protein in the lysates. Immunoblotting was performed as describes previously 44 . Primary antibodies used were directed against viperin (rabbit polyclonal diluted 1:2500), GAPDH (rabbit polyclonal diluted 1:5000), IRAK1 (rabbit polyclonal diluted 1:4000), TRAF6 (mouse monoclonal diluted 1:500) and GAPDH (mouse monoclonal diluted 1:5000). Rabbit polyclonal ubiquitin antibody was used at a dilution of 1:1000. Blots were visualized, and band intensities quantified using a Bio-Rad ChemiDoc Touch imaging system. Integrated density measurements were done using ImageJ software.
Quantitative measurements of protein expression levels reported here represent the average of at least three independent biological replicates.
Immunoprecipitation Assay
Cells were rinsed twice with ice-cold PBS, harvested in P40 lysis buffer (50 mM Tris, pH 7.4, 1% Triton X-100, 150 mM NaCl, 10% glycerol, 1 mM EDTA, 10 mM NaF, and 0.2 mM phenylmethylsulfonyl fluoride with protease inhibitor cocktail from Sigma), and briefly sonicated. Lysates were collected by centrifugation at 12,000 × g for 15 minutes at 4°C. For immunoprecipitation, ratio of suspension to packed gel volume was 2:1. Resin pre-equilibration was done as per the manufacturer's protocol. Three hundred microliters of a 1:1:1 ratio of cell lysates was added and incubated for 16 hours at 4°C with gentle rotation. Beads were pelleted by centrifugation at 5,000 × g for 30 seconds at 4°C and washed three times with washing buffer (50 mM Tris, pH 7.4,150 mM NaCl, 10% glycerol, 1 mM EDTA, 10 mM NaF, and 0.2 mM phenylmethylsulfonyl fluoride with protease inhibitor cocktail from Sigma). Immunocomplexes were eluted by boiling in SDS-PAGE sample buffer, separated by SDS-PAGE, and transferred to a nitrocellulose membrane. Membranes were blocked for 2 h at room temperature in TBST buffer (20 mM Tris, pH 7.5, 137 mM NaCl, and 0.1% Tween 20) containing 5% nonfat dry milk, followed by overnight incubation at 4°C in TBST buffer containing 3% nonfat dry milk and the appropriate primary antibody. Membranes were washed three times in TBST and then incubated for 2 h at room temperature with the secondary IgG-coupled horseradish peroxidase antibody.
The membranes were washed three times with TBST, and the signals were visualized with enhanced chemiluminescence reagent as described in immunoblotting.
Statistical analyses
Results from all studies were compared with unpaired two-tailed Student's t test using GraphPad Prism 5 software. P values less than 0.05 were considered significant.
SAM cleavage assay
HEK 293T cells transfected with viperin, and/or IRAK1 and TRAF6 were harvested from one 10 cm diameter tissue culture plate each, resuspended in 500 µl of anoxic Tris-buffered saline (50 mM Tris-Cl, pH 7.6, 150 mM NaCl) containing 1% Triton X-100, sonicated within an anaerobic glovebox (Coy Chamber), and centrifuged at 14,000 g for 10 min. Dithiothreitol (DTT;5 mM) and dithionite (5 mM) were added to the cell lysate. The assay mixture was incubated at room temperature for 30 min prior to starting the reaction by the addition of SAM (200 µM). The assay was incubated for 60 min at room temperature, after which the reaction stopped by heating at 95 °C for 10 min. The solution was chilled to 4 °C, and the precipitated proteins were removed by centrifugation at 14,000 rpm for 25 min. The supernatant was then extracted with acetonitrile.
Samples were analyzed in triplicate by UPLC-tandem mass spectrometry as described previously 44 . For nucleotide triphosphate assays, the different nucleotides were added at 300 µM
